Literature DB >> 11464290

Modulation of p53 dependent gene expression and cell death through thioredoxin-thioredoxin reductase by the Interferon-Retinoid combination.

J Hu1, X Ma, D J Lindner, S Karra, E R Hofmann, S P Reddy, D V Kalvakolanu.   

Abstract

We have shown earlier that the IFN-beta and all-trans retinoic acid (RA) combination, but not the single agents, induces death in several tumor cell lines. Employing a genetic technique we have identified several Genes associated with Retinoid-IFN induced Mortality (GRIM). One of the GRIMs was human thioredoxin reductase (TR), a redox enzyme. Since the overexpressed TR augments IFN/RA stimulated cell death, we explored the mechanisms of TR-mediated death. Here we show that TR augments cell death by upregulating the transcriptional activity of p53 tumor suppressor. This process does not involve a physical increase in levels of p53. Using redox inactive mutants of TR and its substrate, thioredoxin (Trx), we demonstrate that IFN/RA-induced regulation of p53 dependent gene expression requires TR and Trx. In contrast-over-expression of wildtype TR or Trx augment the p53 dependent gene expression in response to IFN/RA treatment. Consistent with these results an increased DNA binding activity of p53 was noted in the presence of TR. These studies identify a novel mechanism of p53 mediated cell death regulation involving redox enzymes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11464290     DOI: 10.1038/sj.onc.1204585

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

1.  Cytosolic, mitochondrial thioredoxins and thioredoxin reductases in Arabidopsis thaliana.

Authors:  Claire Bréhélin; Christophe Laloi; Aaron T Setterdahl; David B Knaff; Yves Meyer
Journal:  Photosynth Res       Date:  2004       Impact factor: 3.573

2.  Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival.

Authors:  Sally Järvelä; Järvelä Sally; Helena Bragge; Bragge Helena; Niina Paunu; Paunu Niina; Timo Järvelä; Järvelä Timo; Leo Paljärvi; Paljärvi Leo; Hannu Kalimo; Kalimo Hannu; Pauli Helén; Helén Pauli; Vuokko Kinnula; Kinnula Vuokko; Ylermi Soini; Soini Ylermi; Hannu Haapasalo; Haapasalo Hannu
Journal:  J Neurooncol       Date:  2006-04       Impact factor: 4.130

Review 3.  The A to Z of modulated cell patterning by mammalian thioredoxin reductases.

Authors:  Markus Dagnell; Edward E Schmidt; Elias S J Arnér
Journal:  Free Radic Biol Med       Date:  2017-12-24       Impact factor: 7.376

Review 4.  TrxR1 as a potent regulator of the Nrf2-Keap1 response system.

Authors:  Marcus Cebula; Edward E Schmidt; Elias S J Arnér
Journal:  Antioxid Redox Signal       Date:  2015-06-24       Impact factor: 8.401

5.  Redox Regulation of Apoptosis before and after Cytochrome C Release.

Authors:  Quan Chen; Meredith Crosby; Alex Almasan
Journal:  Korean J Biol Sci       Date:  2003-03

Review 6.  The Yeast Saccharomyces cerevisiae as a Model for Understanding RAS Proteins and their Role in Human Tumorigenesis.

Authors:  Giulia Cazzanelli; Flávia Pereira; Sara Alves; Rita Francisco; Luísa Azevedo; Patrícia Dias Carvalho; Ana Almeida; Manuela Côrte-Real; Maria José Oliveira; Cândida Lucas; Maria João Sousa; Ana Preto
Journal:  Cells       Date:  2018-02-19       Impact factor: 6.600

7.  JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1.

Authors:  Kornelia Edes; Pamela Cassidy; Paul J Shami; Philip J Moos
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.